TheProfitWatch

GALT - Galectin Therapeutics Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.05 -0.43 (-8.51%) --- --- 0.0 (0.0%) 0.03 (0.59%) 0.1 (1.98%) 0.0 (0.0%) 0.0 (0.0%)

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.12
Diluted EPS:
-0.12
Basic P/E:
-38.5
Diluted P/E:
-38.5
RSI(14) 1m:
0.0
VWAP:
4.62
RVol:
0.7228

Events

Period Kind Movement Occurred At
1m Price decrease 1m 5.11 -0.05 (-1.06%) Oct 15 13:42
1m Price decrease 1m 5.1 -0.06 (-1.19%) Oct 15 13:27
1m Price decrease 1m 5.01 -0.06 (-1.18%) Oct 15 10:12
1m Price decrease 1m 5.1 -0.08 (-1.45%) Oct 15 10:07
1m Price decrease 1m 5.16 -0.05 (-1.05%) Oct 15 09:56

Related News